Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform
Kaushik Chakravarty, Victor Antontsev, Maksim Khotimchenko, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1912-1912
Open Access | Times Cited: 19

Showing 19 citing articles:

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine
Dolores R. Serrano, Francis C. Luciano, Brayan J. Anaya, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1328-1328
Open Access | Times Cited: 48
Revolutionizing Cardiology through Artificial Intelligence—Big Data from Proactive Prevention to Precise Diagnostics and Cutting-Edge Treatment—A Comprehensive Review of the Past 5 Years
Elena Stamate, Alin Ionut Piraianu, Oana Roxana Ciobotaru, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1103-1103
Open Access | Times Cited: 11
Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
Kartikay Prasad, Vijay Kumar
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100042-100042
Open Access | Times Cited: 34
Anti-viral activity of thiazole derivatives: an updated patent review
Thoraya A. Farghaly, Amani M.R. Alsaedi, Noof A. Alenazi, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 7, pp. 791-815
Closed Access | Times Cited: 28
COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis
Attilio Cavezzi, Roberto Menicagli, Emidio Troiani, et al.
F1000Research (2022) Vol. 11, pp. 102-102
Open Access | Times Cited: 19
Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study
Daniel M. Walden, Maksim Khotimchenko, Hypatia Hou, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 594-594
Open Access | Times Cited: 24
Healthcare 4.0 – Managing a Holistic Transformation
Jameela Al‐Jaroodi, Nader Mohamed, Nader Kesserwan, et al.
2022 IEEE International Systems Conference (SysCon) (2022), pp. 1-8
Closed Access | Times Cited: 15
A hybrid modeling approach for assessing mechanistic models of small molecule partitioning in vivo using a machine learning-integrated modeling platform
Victor Antontsev, Aditya Jagarapu, Yogesh Bundey, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis
Attilio Cavezzi, Roberto Menicagli, Emidio Troiani, et al.
F1000Research (2022) Vol. 11, pp. 102-102
Open Access | Times Cited: 13
A Systematic Review on the Contribution of Artificial Intelligence in the Development of Medicines for COVID-2019
Carla Pires
Journal of Personalized Medicine (2021) Vol. 11, Iss. 9, pp. 926-926
Open Access | Times Cited: 15
Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
Bhaswati Chatterjee, Suman S. Thakur
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
An Update on the Global Treatment of Invasive Fungal Infections
Melissa E. Munzen, Ariana D. Goncalves Garcia, Luis R. Martinez
Future Microbiology (2023) Vol. 18, Iss. 15, pp. 1095-1117
Open Access | Times Cited: 5
SARS-CoV-2 and Hypertension: Evidence Supporting Invasion into the Brain Via Baroreflex Circuitry and the Role of Imbalanced Renin-Angiotensin-Aldosterone-System
Kellysson Bruno Oliveira, Igor Santana de Melo, Bianca Rodrigues Melo da Silva, et al.
Neuroscience Insights (2023) Vol. 18
Open Access | Times Cited: 4
An AI Approach to Generating MIDD Assets Across the Drug Development Continuum
Jeffrey S. Barrett, Rahul K. Goyal, Jogarao Gobburu, et al.
The AAPS Journal (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 4
In Silico Simulation of the Systemic Drug Exposure Following the Topical Application of Opioid Analgesics in Patients with Cutaneous Lesions
Maksim Khotimchenko, Victor Antontsev, Kaushik Chakravarty, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 284-284
Open Access | Times Cited: 8
Paving New Roads Using Allium sativum as a Repurposed Drug and Analyzing its Antiviral Action Using Artificial Intelligence Technology
Manar Atoum, Kanchi Ravi Padma, K. R. Don
Deleted Journal (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Healthcare 4.0 significance and benefits affirmed by the COVID-19 pandemic
Jameela Al‐Jaroodi, Nader Mohamed
Elsevier eBooks (2022), pp. 307-330
Closed Access | Times Cited: 3
A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus
Suehyun Lee, Seongwoo Jeon, Hun‐Sung Kim
Endocrinology and Metabolism (2022) Vol. 37, Iss. 2, pp. 195-207
Open Access | Times Cited: 1
A Synergistic Broad-Spectrum Viral Entry Blocker: In-Silico Approach
Priyank Purohit, Ravi Kumar Mittal, Vikram Sharma
Biointerface Research in Applied Chemistry (2022) Vol. 13, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Page 1

Scroll to top